Jin Medical Reports Revenue Dip Amid Weakened Japanese Yen

The Changzhou-based rehabilitation equipment manufacturer posted a net loss of $0.2 million for the six months ending March 31, 2026, reversing a small profit recorded during the same period last year. CEO Erqi Wang attributed the revenue shortfall primarily to the weakening Japanese Yen, which pressured the purchasing power of the company’s largest customer, Nissin. This currency friction led to a reduction in wheelchair orders, though sales in the core segment remained relatively stable.

Operational challenges further impacted the results, particularly the cessation of electric scooter sales after the company failed to secure necessary qualifications. This contributed to a 59.1% drop in revenue from "other products." Despite these headwinds, the company saw its gross margin improve to 26.9%, up from 24.3% the prior year, citing better inventory management and operating efficiency. Looking ahead, Jin Medical is focusing on expanding its production capacity and increasing research and development investment, which rose by 33.4% during this reporting period to support long-term product innovation.